Literature DB >> 22765500

Revising and refining the epilepsy classification system: priorities from a developing world perspective.

Gretchen L Birbeck1.   

Abstract

Although the technical and human resources for epilepsy care and classification are located largely in high income countries, most people with epilepsy reside in developing regions of the world. Advances over the past two decades in the clinical and basic neurosciences have transformed epilepsy care and largely drive the present need for a revised epilepsy classification. These advances have been mirrored by new knowledge about epilepsy in tropical, resource limited settings. A nonhierarchical, multidimensional approach to classification that includes dimensions that can be ascertained in, and are relevant to, resource-limited settings is needed. Such a classification system could be designed for relevance at tertiary care settings in developed regions as well as primary health care settings in developing regions. Insights from the global use of such a classification approach would also offer opportunities to gain complementary information regarding epilepsy across a broad range of settings and could provide new insights into epilepsy and epileptogenesis. Failure to develop a classification inclusive of the developing world would exclude 80% of the epilepsies globally. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2012        PMID: 22765500      PMCID: PMC3397392          DOI: 10.1111/j.1528-1167.2012.03554.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

Review 1.  The etiologic classification of epilepsy.

Authors:  Simon D Shorvon
Journal:  Epilepsia       Date:  2011-03-30       Impact factor: 5.864

2.  Global burden of disease.

Authors:  L Eisenberg
Journal:  Lancet       Date:  1997-07-12       Impact factor: 79.321

Review 3.  [Incidence of epilepsy and epileptic syndromes in children in the province of Albacete].

Authors:  I Onsurbe Ramírez; M Hernández Rodríguez; J M Aparicio Meix; C Carrascosa Romero
Journal:  An Esp Pediatr       Date:  1999-08

4.  Causes of death among people with convulsive epilepsy in rural West China: a prospective study.

Authors:  J Mu; L Liu; Q Zhang; Y Si; J Hu; J Fang; Y Gao; J He; S Li; W Wang; J Wu; J W Sander; D Zhou
Journal:  Neurology       Date:  2011-06-08       Impact factor: 9.910

5.  Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy.

Authors: 
Journal:  Epilepsia       Date:  1989 Jul-Aug       Impact factor: 5.864

6.  Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study.

Authors:  Gretchen L Birbeck; Malcolm E Molyneux; Peter W Kaplan; Karl B Seydel; Yamikani F Chimalizeni; Kondwani Kawaza; Terrie E Taylor
Journal:  Lancet Neurol       Date:  2010-11-04       Impact factor: 44.182

7.  Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.

Authors:  Patrick Kwan; Alexis Arzimanoglou; Anne T Berg; Martin J Brodie; W Allen Hauser; Gary Mathern; Solomon L Moshé; Emilio Perucca; Samuel Wiebe; Jacqueline French
Journal:  Epilepsia       Date:  2009-11-03       Impact factor: 5.864

8.  Increased risk of adverse neurological development for late preterm infants.

Authors:  Joann R Petrini; Todd Dias; Marie C McCormick; Maria L Massolo; Nancy S Green; Gabriel J Escobar
Journal:  J Pediatr       Date:  2008-12-10       Impact factor: 4.406

9.  Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy.

Authors: 
Journal:  Epilepsia       Date:  1981-08       Impact factor: 5.864

10.  The global burden of epilepsy.

Authors:  Matilde Leonardi; T Bedirhan Ustun
Journal:  Epilepsia       Date:  2002       Impact factor: 5.864

View more
  8 in total

Review 1.  Proposed International League Against Epilepsy Classification 2010: new insights.

Authors:  Vrajesh Udani; Neelu Desai
Journal:  Indian J Pediatr       Date:  2014-08-15       Impact factor: 1.967

Review 2.  State of the Art Approach to the Classification of Epileptic Seizures and Epilepsies.

Authors:  Ebru Barçin; Berrin Aktekin
Journal:  Noro Psikiyatr Ars       Date:  2014-09-01       Impact factor: 1.339

3.  Text Classification towards Detecting Misdiagnosis of an Epilepsy Syndrome in a Pediatric Population.

Authors:  Ryan Sullivan; Robert Yao; Randa Jarrar; Jeffrey Buchhalter; Graciela Gonzalez
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

Review 4.  Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management.

Authors:  Andrea Sylvia Winkler
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

5.  Adverse effects & drug load of antiepileptic drugs in patients with epilepsy: Monotherapy versus polytherapy.

Authors:  Rupa Joshi; Manjari Tripathi; Pooja Gupta; Sheffali Gulati; Yogendra Kumar Gupta
Journal:  Indian J Med Res       Date:  2017-03       Impact factor: 2.375

6.  No association of GABRA1 rs2279020 and GABRA6 rs3219151 polymorphisms with risk of epilepsy and antiepileptic drug responsiveness in Asian and Arabic populations: Evidence from a meta-analysis with trial sequential analysis.

Authors:  Tiejun Zhang; Yi Yang; Xiutian Sima
Journal:  Front Neurol       Date:  2022-09-14       Impact factor: 4.086

Review 7.  Epilepsy care guidelines for low- and middle- income countries: From WHO mental health GAP to national programs.

Authors:  Juri Katchanov; Gretchen L Birbeck
Journal:  BMC Med       Date:  2012-09-24       Impact factor: 8.775

Review 8.  Classifying epilepsy pragmatically: Past, present, and future.

Authors:  Nathan A Shlobin; Gagandeep Singh; Charles R Newton; Josemir W Sander
Journal:  J Neurol Sci       Date:  2021-05-29       Impact factor: 4.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.